Company · Healthcare · AI
Sydney, NSW
Every investor coverage indicates participated in a round Garvan Institute of Medical Research raised.
Investors whose own portfolio pages list Garvan Institute of Medical Research, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Leftfield Group | its portfolio page ↗ |
Companies Garvan Institute of Medical Research acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Associate Professor Jodie Ingles | Laboratory Head | Women's Agenda |
| Russell Scrimshaw | Non-Executive Director | Australian FinTech |
Stories naming Garvan Institute of Medical Research. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Amplia has locked in the design of its PRROSE phase two study pairing narmafotinib with chemotherapy in ovarian cancer, to run with ANZGOG across Australia and New Zealand, recruiting about 26 patients.
Biotech Amplia Therapeutics has completed planning for its PRROSE phase two trial pairing narmafotinib with chemotherapy in ovarian cancer, working with ANZGOG, with patient recruitment targeted before the end of 2026.
Veterinary biotech Gamgee has raised a four million dollar seed round led by Founders Fund, launching from Y Combinator to develop personalised mRNA cancer vaccines for dogs.
Also newshub.medianet.com.au·Dealroom·thesaasnews.com·kucoin.com
Rampersand's April newsletter: an essay on AI services startups, model releases from Anthropic and Meta, Firmus Technologies' $505 million raise, Dexibit's sale to accesso, plus portfolio jobs, events and market commentary.
Also Dealroom·Cut Through Venture·Startup Daily·SmartCompany·SmartCompany·Forbes Australia·Business News Australia·Forbes Australia·Forbes Australia·Mirage News
NSW Health has granted social enterprise Franklin Women two years of support to grow its team and systems, backing its community and mentoring program for women in health and medical research.
Ignition Advice appoints Russell Scrimshaw as deputy chairman and non-executive director, adds two business development hires, and recalls its 2020 Series B raise with Morgan Stanley Wealth Management.